Detalhe da pesquisa
1.
Gene expression markers in peripheral blood and outcome in patients with platinum-resistant ovarian cancer: A study of the European GANNET53 consortium.
Int J Cancer
; 2024 Apr 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-38676430
2.
Discordance between GCIG CA-125 progression and RECIST progression in the CALYPSO trial of patients with platinum-sensitive recurrent ovarian cancer.
Br J Cancer
; 130(3): 425-433, 2024 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-38097739
3.
Updated progression-free survival and final overall survival with maintenance olaparib plus bevacizumab according to clinical risk in patients with newly diagnosed advanced ovarian cancer in the phase III PAOLA-1/ENGOT-ov25 trial.
Int J Gynecol Cancer
; 34(4): 550-558, 2024 Apr 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38129136
4.
Left Ventricular Ejection Fraction in Patients With Ovarian Cancer Treated With Avelumab, Pegylated Liposomal Doxorubicin, or Both.
Oncologist
; 28(10): e977-e980, 2023 10 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-37665777
5.
Neoadjuvant chemotherapy with or without nintedanib for advanced epithelial ovarian cancer: Lessons from the GINECO double-blind randomized phase II CHIVA trial.
Gynecol Oncol
; 170: 186-194, 2023 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36706645
6.
Evaluation of Scores to Reflect Toxicity Impact on Quality of Life of Patients With Platinum-Resistant Ovarian Cancer: AURELIA Substudy.
J Natl Compr Canc Netw
; 21(5): 473-479.e4, 2023 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-37156482
7.
Olaparib plus Bevacizumab as First-Line Maintenance in Ovarian Cancer.
N Engl J Med
; 381(25): 2416-2428, 2019 12 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-31851799
8.
Comparison of global treatment guidelines for locally advanced cervical cancer to optimize best care practices: A systematic and scoping review.
Gynecol Oncol
; 167(2): 360-372, 2022 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-36096973
9.
Efficacy of maintenance olaparib plus bevacizumab according to clinical risk in patients with newly diagnosed, advanced ovarian cancer in the phase III PAOLA-1/ENGOT-ov25 trial.
Gynecol Oncol
; 164(2): 254-264, 2022 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-34952708
10.
Efficacy and safety of olaparib according to age in BRCA1/2-mutated patients with recurrent platinum-sensitive ovarian cancer: Analysis of the phase III SOLO2/ENGOT-Ov21 study.
Gynecol Oncol
; 165(1): 40-48, 2022 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-35115180
11.
Proportions and incidence of locally advanced cervical cancer: a global systematic literature review.
Int J Gynecol Cancer
; 32(12): 1531-1539, 2022 12 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-36241221
12.
Avelumab alone or in combination with chemotherapy versus chemotherapy alone in platinum-resistant or platinum-refractory ovarian cancer (JAVELIN Ovarian 200): an open-label, three-arm, randomised, phase 3 study.
Lancet Oncol
; 22(7): 1034-1046, 2021 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-34143970
13.
Olaparib tablets as maintenance therapy in patients with platinum-sensitive relapsed ovarian cancer and a BRCA1/2 mutation (SOLO2/ENGOT-Ov21): a final analysis of a double-blind, randomised, placebo-controlled, phase 3 trial.
Lancet Oncol
; 22(5): 620-631, 2021 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-33743851
14.
Molecular and clinical predictors of improvement in progression-free survival with maintenance PARP inhibitor therapy in women with platinum-sensitive, recurrent ovarian cancer: A meta-analysis.
Cancer
; 127(14): 2432-2441, 2021 07 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-33740262
15.
Predicting tumor response and outcome of second-look surgery with 18F-FDG PET/CT: insights from the GINECO CHIVA phase II trial of neoadjuvant chemotherapy plus nintedanib in stage IIIc-IV FIGO ovarian cancer.
Eur J Nucl Med Mol Imaging
; 48(6): 1998-2008, 2021 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-33221969
16.
Concordance of BRCA mutation detection in tumor versus blood, and frequency of bi-allelic loss of BRCA in tumors from patients in the phase III SOLO2 trial.
Gynecol Oncol
; 163(3): 563-568, 2021 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-34742578
17.
Evaluation of surgical resection in advanced ovarian, fallopian tube, and primary peritoneal cancer: laparoscopic assessment. A European Network of Gynaecological Oncology Trial (ENGOT) group survey.
Int J Gynecol Cancer
; 30(6): 819-824, 2020 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-32354792
18.
Early treatment modifications improve chemotherapy adherence in ovarian cancer patients ≥70â¯years.
Gynecol Oncol
; 153(3): 616-624, 2019 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-30905433
19.
Exploratory outcome analyses according to stage and/or residual disease in the ICON7 trial of carboplatin and paclitaxel with or without bevacizumab for newly diagnosed ovarian cancer.
Gynecol Oncol
; 152(1): 53-60, 2019 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30449719
20.
Real-world effectiveness of bevacizumab based on AURELIA in platinum-resistant recurrent ovarian cancer (REBECA): A Korean Gynecologic Oncology Group study (KGOG 3041).
Gynecol Oncol
; 152(1): 61-67, 2019 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30409490